Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Merck Sharp & Dohme Corp.
Current Parent Company: Merck
Penalty: $201,975,000
Year: 2012
Date: April 20, 2012
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: drug or medical equipment safety violation
Mega-Scandal: Improper Drug Marketing
Violation Description: Merck agreed to pay $201 million to resolve multistate litigation alleging that it marketed its drug Vioxx for uses not approved by the United States Food and Drug Administration and misrepresented the cardiovascular safety of the drug, causing false claims to be submitted to state Medicaid programs. This was part of a larger $950 million civil and criminal settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.